"Shire was the top FTSE 100 gainer yesterday amid talk of a £7.25 billion bid from Pfizer, the American pharmaceutical giant. A price of £13 a share was mentioned, probably because this was the peak that Shire reached in September before worries over slow US sales of its Vyvanse hyperactivity drug dragged it down. "
http://business.timesonline.co.uk/tol/business/markets/article3556814.ece
Saturday, March 15, 2008
SHP
